BIOCHEMICAL SOCIETY TRANSACTIONS recovery of urine from small animals over lengthy periods of time, it must be concluded that the value of measurements of enzyme activity in urine in experimental toxicology is severely limited.
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The hepatocarcinogen dimethylnitrosamine is metabolized by rat hepatic preparations to methanol and formaldehyde (Lake et nl., 1975) . Although the hepatic degradation of dimethylnitrosamine has been postulated to involve an initial demethylation step (Heath, 1962; Magee &Barnes, 1967 ), the precise mechanism remains to be elucidated.
In our investigations into the properties of the enzymic system@) responsible for hepatic dimethylnitrosamine degradation we have shown that dimethylnitrosamine demethylase is more stable to storage than a number of cytochrome P-450-dependent mixed-function oxidase enzymes (Lake et al., 1974) . This property is in keeping with those of known non-cytochrome P-450-dependent N-oxidase enzymes (Beckett, 1971 ; Zieg!er & Pettit, 1964) . Additionally, aminoacetonitrile has been shown to be a potent inhibitor of dimethylnitrosamine metabolism both in viuo and in vitro (Fiume et al., 1970; Hadjiolov & Mundt, 1974) . However, in addition to its lathyrogenic properties, aminoacetonitrile is a potent inhibitor of amine oxidase enzymes (Riceberg et al., 1975) . In the present study we have investigated the hypothesis that hepatic dimethylnitrosamine degradation may proceed through an N-oxide intermediate catalysed by a microsomal amine oxidase enzyme.
Male Sprague-Dawley rats (80-15Og) were used in the present studies; they were allowed free access to laboratory diet and water. Assays of dimethylnitrosamine demethylase (Lake et al., 1974) , ethylmorphine N-demethylase (Holtzman et al., 1968) and aniline 4-hydroxylase (Nakanishi et al., 1971) were performed on hepatic postmitochondria1 supernatant fractions. The latter two enzymes were chosen to typify Type I and Type I1 substrate interactions respectively of the hepatic microsomal mixedfunction-oxidase system (Schenkman et al., 1967) .
The addition of aminoacetonitrile produced a marked inhibition of dimethylnitrosamine metabolism in uitro without any significant inhibition of either of the two mixed-function oxidases measured (Table 1 ). Both pargyline (N-methyl-Npropargylbenzylamine) and nialamide [N-benzyl-8-(isonicotiny1hydrazine)propionarnide], which are also amine oxidase inhibitors (Abeles & Tashjian, 1975; Von Voigtlander & Losey, 1976) , also inhibited hepatic dimethylnitrosamine degradation.
Two distinct classes of amine oxidase enzymes are known to exist in mammalian tissues (Gorkin, 1966) , namely monoamine oxidase (EC 1.4.3.4) and diamine oxidase (EC 1.4.3.6). As aminoacetonitrile, pargyline and nialamide are generally considered to be inhibitors of monoamine oxidases, the addition of substrates of monoamine oxidase, but not of diamine oxidase would be expected to have similar effects. Indeed, the 563rd MEETING, LONDON inhibited hepatic dimethylnitrosamine demethylase, whereas the diamine oxidase substrate cadaverine (Hill & Bardsley, 1975) was ineffective. The present data tend to support the hypothesis that the hepatic degradation of this nitrosamine in the rat proceeds through an N-oxide intermediate catalysed by a microsomal amine oxidase enzyme.
